From January 1, 2024 to March 31, 2024, the company has repurchased 310,912 shares, representing 0.23% for CNY 14.91 million. With this, the company has completed the repurchase of 607,326 shares, representing 0.45% for CNY 34.9 million under the buyback announced on November 13, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.64 CNY | -3.13% | -6.50% | -49.34% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.34% | 666M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- 688202 Stock
- News Shanghai Medicilon Inc.
- Tranche Update on Shanghai Medicilon Inc.'s Equity Buyback Plan announced on November 13, 2023.